期刊文献+

多靶区三维适形放疗在胸部肿瘤的临床应用 被引量:1

Efficacy of multi-target three-dimensional conformal radionthrapy on the chest tumaor.
下载PDF
导出
摘要 目的研究胸部多病灶肿瘤行多靶区三维适形放射治疗的可行性及应用价值.方法对36例胸部原发肿瘤肺内纵隔转移或双肺多发转移瘤等晚期肿瘤,采用多靶区三维适形放射治疗,优化指标:照射靶区尽可能采用PET/CT定位,靶区以2~4个为宜,采用共面或非共面多野照射,每次剂量2Gy,5次/周,或5~8Gy/次,3次/周,均为90%剂量曲线包绕PTV,总照射剂量或生物等效剂量70~80Gy,在放疗结束后2月行胸部CT或PET/CT进行评价.结果 36例患者中,2例病灶完全消失(CR),23例病灶明显缩小(PR),有效率(CR+PR)69.4%,放疗中未出现明显放射性肺炎、放射性食管炎.结论晚期胸部肿瘤或转移瘤应用三维适形放射治疗采用多靶区治疗,局部控制率高,有较好的近期疗效,早期并发症低,患者可耐受. Objective To evaluate the feasibility and application of the multi - target three - dimensional conforreal radiotherapy on the chest tumor. Methods Thirty six cases of the chest tumor of the lung and/or mediastinum metastases or lung metastases cancer were treated by the multi - target of three - dimensional conformal radiotherapy. The optimized index :we tried to orient the irradiating target by PET/CT. There were 2 to 4 targets ,and we radiated by coplanarity or uncoplanarity planning target volume received a minimum of 90% of the prescribed dose was given in 2Gy / fraction , 5 fractions per week or 5 - 8Gy / fraction, 3 fractions per week, with the total dose ranging from 70 to 80Gy, all patients were evaluated by CT or PET/CT after 2 - month radiotherapy. Results Among the 36 cases, the tumor of 2 cases were disappeared, 23 cases were reduced obviously . The effective rate ( CR + PR ) was 69. 4% , and no acute radiation - induced penumonitis and radiation - induced esophagitis . Conclusion The local control rate of the patients with the chest tumor treated by the multi - target of three - dimensional conformal radiotherapy are obvious, the recent effect is good , there is no early severe complications , the patients are well tolerated.
出处 《现代肿瘤医学》 CAS 2005年第5期651-652,共2页 Journal of Modern Oncology
关键词 多靶区 三维适形放疗 胸部肿瘤 multi - target three - dimensional conformal radiotherapy chest tumor
  • 相关文献

参考文献7

  • 1Niemieko A,Goitein M. Modeling of normal tissue response to radiation:the critical volume model[J]. Int J Radiat Oncol Biol Phys,1993,25:135~145.
  • 2Graham MV,Purdy JA,Emami B,et al. Clinical dose-volume historgram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)[J] . Int J Radiat Oncol Biol Phys,1999,45(2):323~329.
  • 3屠规益.功能保全性肿瘤外科手术[J].中华肿瘤杂志,1995,17(6):473-474. 被引量:14
  • 4Shimizu S,Shirato H,Kagei K,et al.Impact of respiratory movement on the computed tomographic images of small lung tumor in three-dimensional (3D) radiotherapy[J]. Int J Radiat Oncol Biol Phys,2000,46:1127~1133.
  • 5Ekberg L,Holmberg O,Wittgren L,et al.What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer[J]. Radioth Oncol,1998,48:71~77.
  • 6吴君心,余子豪.低剂量放射超敏感性及潜在的临床意义[J].中华放射肿瘤学杂志,2002,11(1):60-63. 被引量:5
  • 7蒋国樑.局部晚期非小细胞肺癌的放射治疗[J].中国癌症杂志,2003,13(5):394-397. 被引量:15

二级参考文献19

  • 1Thomas M, Rube C, Semik M, et al. Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage Ⅲ non.-mnall-cell lung cancer[J] .J Clin Oncol,1999,17(4) :1185.
  • 2Vora SA, Daly BD, Blaszkowsky L, et al. High dose radiation therapy and chemotherapy as induction treatment for stage Ⅲ non-samll-cell lung carcinoma[ J ]. Cancer,2000,89 (9) : 1946-1952.
  • 3Adelstein DJ, Rice TW, Rybicki LA, et al. Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage Ⅲ non-small-cell lung cancer[ J]. Lung Cancer,2002,36(2) :167-170.
  • 4Suntharalingam M, Sonett JR, Hass ML, et al. The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus tumors [J ].Cancer J,2000;6(6) :365-371.
  • 5Cesario A, Margaritora S, Trodella L, et al. Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer[ J]. Lung Cancer,2002,37(2) :207-212.
  • 6Komaki R, Seiferheld W, Ettinger D, et al. Randomized phase II chemotherapy and radiotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer:long-term follow-up of RTOG 92-04 [ J ]. Int J Radiat Oncol Biol Phys,2002,53(3) :548-557.
  • 7Rosenman JG, Halle JS, Socinski MA, et al. High-dose conformal radiotherapy for treatment of stage Ⅲa/Ⅲb non-small-cell lung cancer: technical issues and results of a phase Ⅰ/Ⅱ trial[J]. Int J Radiat Oncol Biol Phys,2002 ,54(2) :348-356.
  • 8Herskovic A, Fisher J, Orton B, et al. Accelerated hyperfractionation in patients with non-small cell bronchogenic cancers as a cost-effective and user and patient-friendly schedule[J]. Cancer Invest,2000,18(6) :537-543.
  • 9Antonadou D, Coliarakis N, Synodinou M, et al. Randomized phase Ⅲ trial of radiation treatment + / - amifostine in pstients with advanced-stage lung cancer [J ]. Int J Radiat Oncol Biol Phys,2001 ,51 (4) :915-922.
  • 10Vaganay-Juery S,Muller C,Abdulkarim b,et al.Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irrdadiation[].British Journal of Cancer.2000

共引文献31

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部